ArticleInsights into imaging2026
Systemic inflammatory factors combined with HR-VWI-based plaque vulnerability discriminate ischemic phenotypes and predict prognosis in patients with intracranial atherosclerosis.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe relationship between systemic inflammation, plaque vulnerability, and stroke phenotypes in intracranial atherosclerotic stenosis (ICAS) is unclear. This study investigated inflammatory markers' association with high-risk plaques and their value in differentiating stroke phenotypes and predicting prognosis. MATERIALS AND
methods298 symptomatic ICAS patients were classified into acute ischemic stroke (AIS, n = 207) and delayed perfusion (DP, n = 91) groups using multimodal MRI. Plaque vulnerability was graded based on high-resolution vessel wall imaging, inflammatory indices calculated, and associations assessed using regression and mediation analysis.
resultsAIS patients had higher systemic inflammation and more high-risk plaques (all p < 0.05). Each Systemic Inflammation Response Index (SIRI) unit increase was associated with 32.4% higher AIS risk (p = 0.027) and nearly threefold increased 90-day poor outcome risk (p < 0.001). In an exploratory mediation analysis aimed at understanding how these markers jointly differentiate the two phenotypes, the association between SIRI and AIS was partially (25.9%) statistically accounted for by high-risk plaque features. A comprehensive model integrating clinical, inflammatory, and imaging markers effectively differentiated AIS from DP (AUC = 0.794). In an exploratory prognostic analysis with a small number of poor outcomes, adding SIRI improved the AUC from 0.610 to 0.959, with internal validation supporting robustness (mean cross-validated AUC: 0.919-0.939), p < 0.05. Associations were more pronounced in males.
conclusionsSystemic inflammation is associated with ischemic phenotype in ICAS, and this association may be partially explained by plaque vulnerability. Combined assessment effectively differentiates stroke phenotypes and predicts prognosis, particularly in males, supporting multi-parametric models for early identification of at-risk patients. KEY POINTS: Question: Can systemic inflammatory markers combined with high-risk plaque features discriminate acute ischemic stroke from delayed perfusion and predict prognosis in patients with intracranial atherosclerotic stenosis?
findingsSystemic inflammation response index was independently associated with acute ischemic phenotypes and poor prognosis. Multi-parametric models improved phenotype discrimination (AUC = 0.794) and prognosis prediction (cross-validated AUC: 0.919-0.939). Critical relevance statement: Systemic inflammation response index is associated with acute ischemic stroke in intracranial atherosclerotic stenosis, an association partially mediated by high-risk plaque features. Combined assessment of inflammatory and imaging biomarkers improves stroke phenotyping and prognosis prediction, particularly in male patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.